12-03 :: March/April 2012
nanotimes
Companies Facts
Advertisement
13
Group Ltd., an established company that provides an extensive range of pharmaceutical services. In this agreement, Affymetrix has exclusive rights to distri- bute Almac’s Xcel™ array for research use in biomar- ker discovery for multiple disease areas, including cancer.
A
The Almac’s Xcel™ array is a microarray, built on the industry-standard Affymetrix’ GeneChip®
Human Ge-
nome U133 Plus 2.0 Array platform (RUO*), that has been optimized for RNA expression profiling from formalin fixed paraffin embedded (FFPE) samples.
http://www.affymetrix.com
board and leadership team. The Non-Executive Chairman, Mr. Gavin Rezos has agreed to move into the role of Executive Chairman and President, as the Company moves into the commercial licensing phase of the Reactive Surface Treatment (RST) technology and engages with the US Investment Community fol- lowing on from the recent OTC QX quotation in the US. This will require Mr Rezos to spend more time in the US and Europe overseeing the operational and commercial parts of the business and its network overseas. In addition we are also pleased to highlight the details and responsibilities of the current lea-
A
lexium International Group Limited (Alexium) (OTCQX: AXXIY) announced changes to its
ffymetrix, Inc. (NASDAQ: AFFX) has signed a global distribution agreement with Almac
dership team. There are no changes to the Board of Directors.
http://www.alexiuminternational.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79